Vaccinex Gross Margin Growth & History (VCNX)
Vaccinex's gross margin was 100.00% for fiscal 2021.
View full Vaccinex company overviewVaccinex annual gross margin history
2017
2018
2019
2020
2021
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | 100.00% | +0.32 pp |
| 2020 | 2020-12-31 | 99.68% | +37.73 pp |
| 2019 | 2019-12-31 | 61.95% | +104.63 pp |
| 2018 | 2018-12-31 | −42.68% | +35.10 pp |
| 2017 | 2017-12-31 | −77.78% | — |
Vaccinex quarterly gross margin
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q3.20
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2020 | 2020-09-30 | 99.68% | +1.66 pp |
| Q3 2019 | 2019-09-30 | 98.02% | +122.26 pp |
| Q2 2019 | 2019-06-30 | 36.00% | +131.24 pp |
| Q1 2019 | 2019-03-31 | −86.17% | −69.67 pp |
| Q4 2018 | 2018-12-31 | −55.15% | — |
| Q3 2018 | 2018-09-30 | −24.24% | — |
| Q2 2018 | 2018-06-30 | −95.24% | — |
| Q1 2018 | 2018-03-31 | −16.50% | — |
Vaccinex gross margin trends
Between the periods ended 2017-12-31 and 2021-12-31, Vaccinex's gross margin increased from −77.78% to 100.00%, a change of +177.78 percentage points. The latest reported quarter, Q3 2020, shows 99.68%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaccinex source filings ↗